Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
1 hedge funds and large institutions have $545 invested in Lucira Health, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.
83% less funds holding
Funds holding: 6 → 1 (-5)
100% less capital invested
Capital invested by funds: $1.46M → $545 (-$1.46M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EV
Eclipse Ventures
Palo Alto,
California
|
-$1.43M |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$17K |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$7K |
| 4 |
Barclays
London,
United Kingdom
|
-$668 |
| 5 |
CS
Clear Street
New York
|
-$230 |
LHDX Hedge Fund Activity: Q2 2023 in Review
1 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q2 2023, worth a combined $545 — down 100% from $1.46M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LHDX and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Eclipse Ventures, exiting entirely with an estimated $1.43M sold.
- 1 institutional investor held Lucira Health, Inc. Common Stock (LHDX) as of Q2 2023, down from 6 in Q1 2023.
- Funds reported $545 of Lucira Health, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Lucira Health, Inc. Common Stock positions in Q2 2023 and 5 closed out, a net change of -5 holders.
- The largest Lucira Health, Inc. Common Stock seller in Q2 2023 was Eclipse Ventures, an estimated $1.43M sold.
Based on aggregated 13F filings for Q2 2023.